Search

RIGEL PHARMA AWAITS FDA APPROVAL FOR TAVALISSE, BUILDS COMMERCIAL ORG FOR DRUG LAUNCH

The U.S. Food and Drug Administration is set to rule on Tavalisse , an oral spleen tyrosine kinase inhibitor, for adult patients with...

Nominee for top HHS post says he would fix system that encourages pharma companies to raise drug prices

NOMINEE FOR TOP HHS POST SAYS HE WOULD FIX SYSTEM THAT ENCOURAGES PHARMA COMPANIES TO RAISE DRUG PRICES

Senate Democrats on Tuesday pressed President Donald Trump's nominee for the top health post to explain how he would fight skyrocketing...

 
 
 

PFIZER AXING NEUROSCIENCE JOBS, BUT SEEKS NEW VC FUND

Big Pharma Pfizer, on the eve of J.P. Morgan, the biggest biopharma dating event on the year, is to cut around 300 jobs and a number...

2 UNDERAPPRECIATED BIOTECH STOCKS TO BUY IN 2018

Why Horizon Pharma and Sanofi are three cheap stocks worth considering in 2018.

 
 
 
Big Pharma BOOM: Drug prices SOARED in 2017 and you'll never guess who's getting YOUR medicine rebates

BIG PHARMA BOOM: DRUG PRICES SOARED IN 2017 AND YOU'LL NEVER GUESS WHO'S GETTING YOUR MEDICINE REBATES

President Donald J. Trump campaigned, in part, on a pledge to pursue policies that would end the nightmare trend of skyrocketing costs...

Former attorney to pharma bro Martin Shkreli found guilty in fraud scheme

FORMER ATTORNEY TO PHARMA BRO MARTIN SHKRELI FOUND GUILTY IN FRAUD SCHEME

Evan Greebel acted as outside counsel for pharma company Retrophin from 2012 to 2014. Prosecutors alleged during that time Greebel...

 
 
 

FDA ACCEPTS GW PHARMA'S EPIDIOLEX NDA WITH PRIORITY REVIEW FOR LENNOX-GASTAUT SYNDROME AND DRAVET

The PDUFA goal date for completion of the FDA review of the Epidiolex NDA is June 27, 2018.

 
 
 
2017 drug approvals: Records, milestones, and controversies

2017 DRUG APPROVALS: RECORDS, MILESTONES, AND CONTROVERSIES

2017 was a blockbuster year for drug approvals, with 46 new molecular entities and some first-of-their-kind gene therapies given the...

How is health tech addressing the demand for cheaper prescription drugs?

HOW IS HEALTH TECH ADDRESSING THE DEMAND FOR CHEAPER PRESCRIPTION DRUGS?

GoodRx, for example, developed a skill for Amazon's Alexa to track down cheap prescription drugs.

 
 
 

POACHED FROM ASTRAZENECA, NEW PHARMA HEAD LOOKS TO RESUSCITATE GLAXOSMITHKLINE'S CANCER PIPELINE

GlaxoSmithKline will scout for deal opportunities in cancer medicine, as well as immunology, as the drugmaker seeks to rebuild its...

Apprentice secures $2.5 million for augmented reality tool geared toward biopharma manufacturing

APPRENTICE SECURES $2.5 MILLION FOR AUGMENTED REALITY TOOL GEARED TOWARD BIOPHARMA MANUFACTURING

Apprentice, a Jersey City, New Jersey-based startup, has raised $2.5 million from Silverton Partners and Hemi Ventures to improve its...

 
 
 
Plant cure for opioid addiction taking heat from the FDA: Claims of danger most likely linked to its impact on Big Pharma's bottom line

PLANT CURE FOR OPIOID ADDICTION TAKING HEAT FROM THE FDA: CLAIMS OF DANGER MOST LIKELY LINKED TO ITS IMPACT ON BIG PHARMA'S BOTTOM LINE

Kratom, the popular plant-based opioid alternative from Southeast Asia, was the subject of an advisory from the Food and Drug Administration...

 
 
 
Pharma bro felon Martin Shkreli might lose his Wu-Tang album

PHARMA BRO FELON MARTIN SHKRELI MIGHT LOSE HIS WU-TANG ALBUM

It was reportedly the most expensive single album ever sold in the world. And now, infamous businessman Martin Shkreli might be forced...

Feds want Shkreli's Wu-Tang Clan album

FEDS WANT SHKRELI'S WU-TANG CLAN ALBUM

Brooklyn prosecutors say they could seize hated “Pharma Bro” Martin Shkreli's one-of-a-kind Wu-Tang Clan album as part of $7.4 million...

 
 
 
Bio Roundup: Migraine Data, Cancer Drug Combos, Azar Hearing & More

BIO ROUNDUP: MIGRAINE DATA, CANCER DRUG COMBOS, AZAR HEARING & MORE

A pair of migraine drugs made a splash in biotech news this week with published data suggesting that they can reduce the frequency...

Drug discount program 340B is at center of debate between CMS, lawmakers and hospitals

DRUG DISCOUNT PROGRAM 340B IS AT CENTER OF DEBATE BETWEEN CMS, LAWMAKERS AND HOSPITALS

The 340B program requires pharmaceutical companies to give steep discounts to hospitals and clinics that serve high volumes of low-income...

 
 
 

INNATE HOPES DOSING TWEAK WILL SAVE BMS-PARTNERED LIRILUMAB

Innate Pharma has admitted that it can't see an obvious way to bring its cancer antibody lirilumab forward in development after it...

COWEN: Amazon's move into pharma isn't as big of a deal as everyone thinks

COWEN: AMAZON'S MOVE INTO PHARMA ISN'T AS BIG OF A DEAL AS EVERYONE THINKS

Drew Angerer/Getty Images Amazon's move into pharmacy may not be as big a disrupter as the market thinks, John Blackledge of Cowen...